CILCA Arch Registry: Management and Outcomes of Open and Endovascular Repair

NCT04995640 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2021-09-29

No results posted yet for this study

Summary

This registry aims to provide insights on the pathogenic mechanisms that expose subjects with CILCA arch to the increased risk of postoperative complications. So, the CILCA arch registry will capture clinical data and medical images of subjects with CILCA arch treated by surgical or endovascular (TEVAR) means.

Study Design: International Multicenter and Observational registry

Estimated Enrolment: 500 patients, with competitive enrolment.

Clinical Follow up: Postoperatively at 30 days, at 12 months, and yearly after.

Conditions

  • Aortic Arch
  • Aortic Diseases
  • Bovine Arch

Interventions

PROCEDURE

open cardiovascular repair or endovascular treatment (TEVAR)

Surgery type: open cardiovascular repair and endovascular treatment (TEVAR)

Sponsors & Collaborators

  • Ospedale San Donato

    lead OTHER

Principal Investigators

  • Massimiliano Maria Marrocco-Trischitta, MD, PhD · Ospedale San Donato , IRCCS

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2026-04-15
Completion
2026-04-15

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04995640 on ClinicalTrials.gov